DR REDDYS LABS LTD
| Market Cap | $11.81B |
| P/E Ratio | 19.17 |
| Forward P/E | 25.17 |
| Dividend Yield | 0.64% |
| Beta | 0.31 |
| 52W Range | $12.26 - $16.17 |
| # Hedge Funds | 0 |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Sarah Ketterer Causeway Capital Management | 0.00% | $0 | 0 | Sold |
Frequently Asked Questions
What is RDY stock price today?
DR REDDYS LABS LTD (RDY) is currently trading at $14.19. The stock has a 52-week range of $12.26 to $16.17 and a market capitalization of $11.81B.
Is RDY a good stock to buy in 2026?
DR REDDYS LABS LTD has a P/E ratio of 19.2 (forward P/E: 25.2), a dividend yield of 0.64%, and 1-year performance of +12.5%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling RDY stock?
There have been 0 insider transactions for RDY in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has RDY stock performed over the past year?
DR REDDYS LABS LTD (RDY) has returned +12.5% over the past 12 months. The stock traded between $12.26 and $16.17 during this period, and is currently at $14.19.
Which hedge funds own RDY (DR REDDYS LABS LTD)?
1 tracked hedge funds currently hold RDY in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is RDY's market cap and valuation?
DR REDDYS LABS LTD (RDY) has a market capitalization of $11.81B. The trailing P/E ratio is 19.2 and forward P/E is 25.2. The stock is classified in the Healthcare sector.
What is RDY's revenue and profitability?
DR REDDYS LABS LTD reported revenue of $345.83B with net income of $56.59B and a profit margin of 0.16%. The stock has a beta of 0.31.
What sector is RDY in and who are its biggest institutional holders?
DR REDDYS LABS LTD (RDY) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.